Eversense Implantable Glucometer Gets FDA Approval as Alternative to Finger Tests |

Medgadget, 10/06/2019

Partagé par : 

Beesens Teams

Eversense Implantable Glucometer Gets FDA Approval as Alternative to Finger Tests |

"Senseonics, a company out of Germantown, Maryland, won FDA approval for its Eversense continuous glucose monitoring system. The system is intended to be used instead of traditional finger prick tests to make diabetes-related decisions. This is a giant step for the company, which has developed a technology that combines a tiny implant with a wearable transmitter to continuously measure glucose for 90 days at a time...." Lire la suite